A mailing address / phone appears here when the manufacturer includes it in the products FDA label (not all do)
September 2023: FDA placed multiple peptides including CJC-1295 (free base, acetate, DAC variants) and ipamorelin (acetate and free base) on Category 2 of the interim 503A bulks list, signaling significant safety or evidence concerns and effectively halting routine 503A compounding
Next-generation triple agonists (GLP-1/GIP/glucagon) introduce a glucagon component to boost hepatic energy expenditure and browning of white adipose tissue
Pancreatitis: Although rare, semaglutide has been associated with pancreatitis, a potentially serious inflammation of the pancreas
By February 2024, at least 55 cases had been filed
Use of the information is at your own risk, and we are not responsible for any consequences resulting from its use.